Clinical Trial: Interleukin-6 in the Development of Meconium Aspiration Syndrome in Newborn

U.S., Feb. 7 -- ClinicalTrials.gov registry received information related to the study (NCT07394322) titled 'Interleukin-6 in the Development of Meconium Aspiration Syndrome in Newborn' on Jan. 30.

Brief Summary: This trial is intended to assess the serum levels of interleukin-6 as a predictive factor for the occurrence of meconium aspiration syndrome in infants born with MSAF.

Study Start Date: Jan. 01, 2023

Study Type: INTERVENTIONAL

Condition: Meconium Aspiration Syndrome

Intervention: DIAGNOSTIC_TEST: serum interleukin 6

Serum IL-6: An enzyme-linked immunosorbent test (ELISA) that was developed to quantify the amount of the target bound amongst a matched pair of antibodies was the Human IL-6 solid-phase sandwich ELISA. The wells ...